Fufeng Group Limited (HK:0546)
:0546
Want to see HK:0546 full AI Analyst Report?
Top Page
Fufeng Group Limited
(0546)
Select Model
Select Model
Rating:59Neutral
Price Target:
HK$5.50
▼(-31.25% Downside)
Action:Reiterated
Date:06/25/26
The score reflects a mix of very strong valuation (low P/E and high yield) offset by weakening financial quality (margin compression, higher leverage, and notably weak/volatile free cash flow) and clearly bearish technicals (below key moving averages with negative MACD).
Positive Factors
Essential ingredient portfolio
Fufeng supplies staple, low-elasticity ingredients (MSG, amino acids, starches) to food, beverage and animal-nutrition customers. That product mix supports steady, structural demand and makes revenues less cyclical over months, anchoring volume-based cash generation.
Negative Factors
Margin compression
Margins have retraced from prior-cycle highs, indicating weaker pricing power or higher input costs. Sustained compression reduces internal cash generation and returns on invested capital, making the business more sensitive to corn and energy cost volatility over coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Essential ingredient portfolio
Fufeng supplies staple, low-elasticity ingredients (MSG, amino acids, starches) to food, beverage and animal-nutrition customers. That product mix supports steady, structural demand and makes revenues less cyclical over months, anchoring volume-based cash generation.
Read all positive factors
Fufeng Group Limited (0546) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$11.86B
Dividend Yield5.31%
Average Volume (3M)4.55M
Price to Earnings (P/E)4.5
Beta (1Y)0.70
Revenue Growth0.46%
EPS Growth6.62%
CountryHK
Employees17,376
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.98
Shares Outstanding2,507,346,000
10 Day Avg. Volume5,636,047
30 Day Avg. Volume4,549,355
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)0.91
Price to Sales (P/S)0.64
P/FCF Ratio73.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.11Price Target Upside1.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.88
Revenue Forecast (FY)HK$28.86B
Fufeng Group Limited Business Overview & Revenue Model
Company Description
Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China ...
How the Company Makes Money
Fufeng Group makes money primarily by manufacturing and selling bulk food and feed ingredients produced from corn through fermentation and starch processing. Its key revenue streams typically include: (1) Amino acids and flavor enhancers—selling M...
Fufeng Group Limited Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
58
Neutral
Cash Flow
45
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 27.88B | 27.76B | 28.01B | 27.47B | 21.54B |
| Gross Profit | 5.48B | 5.06B | 6.25B | 7.21B | 3.91B |
| EBITDA | 3.90B | 3.44B | 4.47B | 6.26B | 2.89B |
| Net Income | 2.47B | 2.31B | 3.14B | 3.86B | 1.28B |
Balance Sheet | |||||
| Total Assets | 43.73B | 36.09B | 32.56B | 26.39B | 21.51B |
| Cash, Cash Equivalents and Short-Term Investments | 19.50B | 10.03B | 2.83B | 7.08B | 3.59B |
| Total Debt | 18.39B | 11.37B | 9.73B | 5.95B | 4.23B |
| Total Liabilities | 24.26B | 17.75B | 15.24B | 10.89B | 8.83B |
| Stockholders Equity | 19.47B | 18.34B | 17.32B | 15.49B | 12.68B |
Cash Flow | |||||
| Free Cash Flow | 240.73M | 1.73B | -618.75M | 2.61B | 2.28B |
| Operating Cash Flow | 2.91B | 2.96B | 1.70B | 3.60B | 2.77B |
| Investing Cash Flow | -908.09M | -1.10B | -1.51B | -647.64M | -549.54M |
| Financing Cash Flow | 1.79B | 1.10B | -436.59M | 92.41M | 525.07M |
Fufeng Group Limited Technical Analysis
Negative
8.00
Price Trends
6.04
Negative
7.05
Negative
7.72
Negative
Market Momentum
-0.34
Positive
37.84
Neutral
31.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0546, the sentiment is Negative. The current price of 8 is above the 20-day moving average (MA) of 5.50, above the 50-day MA of 6.04, and above the 200-day MA of 7.72, indicating a bearish trend. The MACD of -0.34 indicates Positive momentum. The RSI at 37.84 is Neutral, neither overbought nor oversold. The STOCH value of 31.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0546.
Fufeng Group Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$1.22B | 8.56 | 3.36% | 7.85% | -5.34% | 43.44% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$11.86B | 4.51 | 12.61% | 5.31% | 0.46% | 6.62% | |
59 Neutral | HK$10.33B | -21.85 | -3.31% | 3.48% | 3.39% | -2.32% | |
48 Neutral | HK$2.56B | -2.15 | -39.25% | ― | -9.38% | -5783.70% | |
46 Neutral | HK$827.82M | -12.02 | -3.55% | ― | -16.30% | -113.19% | |
45 Neutral | HK$1.55B | -49.73 | -15.58% | ― | -0.05% | -54.13% |
* Basic Materials Sector Average
HK:0546
Fufeng Group Limited
5.10
-1.64
-24.29%
HK:0336
Huabao International Holdings
3.11
0.25
8.89%
HK:0408
Yip's Chemical Holdings
2.14
0.64
42.29%
HK:3318
China Boton Group Co., Ltd.
2.37
0.77
48.13%
HK:0301
SANVO Fine Chemicals Group Limited
3.74
2.42
183.33%
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.50
0.09
20.73%
Fufeng Group Limited Corporate Events
Fufeng Flags First-Half 2026 Downturn on FX Hit and Weak Additive Prices
Jun 17, 2026
Fufeng Group Limited, a Hong Kong-listed producer of food and feed additives including MSG, xanthan gum, threonine and lysine, derives much of its performance from international markets and is significantly exposed to currency movements between th...
Fufeng Shareholders Approve Dividends, Board Mandates at 2025 AGM
May 29, 2026
Shareholders of Fufeng Group Limited approved all resolutions at the 2025 Annual General Meeting held on 29 May 2026, with no voting restrictions or required abstentions and poll counting overseen by Tricor Investor Services. Investors backed the ...
Fufeng Group Calls 2026 AGM, Proposes Dividends and Share Issue Mandate
Apr 23, 2026
Fufeng Group Limited has called its annual general meeting for 29 May 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and reports for the year ended 31 December 2025. The meeting will also consider a...
Fufeng Group Declares Special Final Dividend for 2025
Mar 27, 2026
Fufeng Group Limited has declared a special final dividend of HKD 0.015 per share for the financial year ended 31 December 2025, reinforcing its practice of returning cash to shareholders. The dividend is subject to shareholder approval on 29 May ...
Fufeng Group Lifts 2025 Profit and Dividends on Stronger Margins
Mar 26, 2026
Fufeng Group Limited reported that its 2025 revenue inched up 0.4% year on year to about RMB27.9 billion, driven mainly by growth in its animal nutrition segment. Gross profit rose 8.4% to roughly RMB5.5 billion on stronger contributions from food...
Fufeng Group Declares Final HKD 0.107 Dividend for 2025
Mar 26, 2026
Fufeng Group Limited has announced a final ordinary cash dividend of HKD 0.107 per share for the financial year ended 31 December 2025, subject to shareholder approval on 29 May 2026. The dividend, payable in Hong Kong dollars, underscores the com...
Fufeng Group Declares Special Cash Dividend for 2025 Financial Year
Mar 26, 2026
Fufeng Group Limited has declared a special cash dividend of HKD 0.015 per share for the financial year ended 31 December 2025, signalling a distribution of excess capital to shareholders. The move underlines the company’s commitment to shar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.